A critical advance in cancer research is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial tumor protector protein is frequently inactivated in various forms of tumors, causing https://hotbookmarkings.com/story21946844/mini-antibodies-restore-tumor-suppressor-p53-the-new-hope-for-malignant-treatment